To help children with rare diseases, we must solve drug delivery

Rare diseases affect many children, but fewer than 5% have approved therapies. Scientists said delivering gene-editing tools to the brain remains a major challenge. While viral vectors often fell short, researchers now use lipid nanoparticles. Last year, a team used this technology to correct a liver mutation in a young patient.